Janwillem Naesens

Insider Reports History

Location
Lexington, MA
Signature
/s/ Andrew Gengos, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Janwillem Naesens:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Cyteir Therapeutics, Inc. Director Common Stock 3.54M $5.98M $1.69 22 Jun 2021 Indirect
Cyteir Therapeutics, Inc. Director Stock Option (Right to Buy) 14.2K 22 Feb 2022 Direct
Cyteir Therapeutics, Inc. Director Series B Convertible Preferred Stock 0 22 Jun 2021 Indirect
Cyteir Therapeutics, Inc. Director Series C Convertible Preferred Stock 0 22 Jun 2021 Indirect

Insider Reports Filed by Janwillem Naesens

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CYT Cyteir Therapeutics, Inc. 22 Feb 2022 1 $0 4 Director 24 Feb 2022, 15:57
CYT Cyteir Therapeutics, Inc. 22 Jun 2021 4 $5M 4 Director 24 Jun 2021, 20:50
CYT Cyteir Therapeutics, Inc. 17 Jun 2021 0 $0 3 Director 17 Jun 2021, 21:40